University of Pittsburgh

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, University of Pittsburgh sits in the top decile of US sponsors by registered trial count (#22 of 15,742 sponsors by registered trial count).

1,238 total trials 160 currently recruiting 917 completed early-phase tilt top decile by trial count

University of Pittsburgh: 1,238 sponsored US clinical trials, 160 recruiting.

University of Pittsburgh sponsors 1,238 registered US clinical trials on ClinicalTrials.gov, 160 of them currently recruiting, and 917 completed. 84 of these trials are in Phase 3-4 (later-stage) and 160 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Depression, with 17 trials.

Top-decile sponsor footprint

University of Pittsburgh ranks in the top decile of sponsors by registered trial count (#22 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

C 66/100

917 of 1,014 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (90.4%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

1,238 total, page 15 of 25

COMPLETED NA

Improving Patient and Family Centered Care in Advanced Critical Illness

NCT01844492

COMPLETED NA

Enriched Autologous Fat Grafting for Treating Pain at Amputation Sites

NCT01645722

COMPLETED

Clinical Quality Improvement of Benzodiazepine-Resistant Alcohol Withdrawal Syndrome

NCT01652326

TERMINATED Phase 3

Hemophilia Adult Prophylaxis Study: Factor VIII in Severe Hemophilia A

NCT01405742

COMPLETED Phase 1

Mobile Phone Text Message Program to Understand Symptoms and Improve Outcomes in Minor Head Injury Patients

NCT01668342

COMPLETED NA

Self-administered Intravaginal 2% Lidocaine Gel Prior to Intrauterine Device Insertion in Nulliparous Women

NCT01534520

COMPLETED NA

Regionalized Pediatric Emergency Care in Rural Pennsylvania

NCT01775033

COMPLETED NA

Effect of Community Pharmacist Intervention on Adherence to Long-Term Medications

NCT02604901

TERMINATED NA

Use of Concentrated Endogenous Autologous Adipose Stromal Cells in Fat Grafts for Craniofacial Trauma

NCT01633892

COMPLETED NA

Assessment and Referral Versus Exercise in Primary Prevention of Falls: PA Healthy Steps Program

NCT01552551

COMPLETED

Ultrasound Assessment of Gastric Emptying

NCT01672424

TERMINATED Phase 3

Phase III Trial of PET/CT vs. CTSurveilance for Head and Neck Cancer

NCT02655068

TERMINATED NA

Determining the Impact of a Medication Delivery Unit on Medication Adherence of Adults With Common Cardiac Conditions

NCT01600677

COMPLETED NA

REMEDIES4D: REdesigning MEDication Intensification Effectiveness Study for Diabetes

NCT01611168

COMPLETED

Temporally-Oriented Subjective Well-being Across Transitions-Resources & Outcomes

NCT01583946

COMPLETED

Hereditary Colorectal and Associated Tumor Registry Study

NCT00633607

TERMINATED Phase 1

Safety and Efficacy of Radiation/Cetuximab Plus EGFR Antisense DNA for Head and Neck Squamous Cell Carcinoma

NCT00903461

COMPLETED NA

Pilot Study of Interpersonal and Social Rhythm Therapy for Subthreshold Bipolar

NCT01520129

COMPLETED Phase 2

Arthritis Foundation Exercise Program & "10 Keys" to Healthy Aging--Prevention Research Center

NCT01616433

COMPLETED NA

Depression Agency-Based Collaboration

NCT01566318

TERMINATED Phase 2

Cooling to Optimize Organ Life in Donor Study

NCT01544530

COMPLETED NA

Furlow Palatoplasty With Tensor Tenopexy

NCT01535131

COMPLETED NA

Comparison of a Technology-based System and an In-person Behavioral Weight Loss Intervention in the Severely Obese

NCT01537796

COMPLETED NA

Gestational Diabetes Diagnostic Methods

NCT01540396

COMPLETED Phase 2

Online Treatments for Mood and Anxiety Disorders in Primary Care

NCT01482806

COMPLETED

Association Between Light Spectrum and Survival After Cataract Surgery

NCT04187157

COMPLETED NA

Enhancing the Detection and Management of Adverse Drug Events in Nursing Homes

NCT01531088

COMPLETED NA

Dexmedetomidine and Adenosine: Therapeutic Use for SVT

NCT01495481

COMPLETED NA

Staying Active With Arthritis: RCT of Physical Activity for Older Adults With Osteoarthritis and Hypertension

NCT01280903

COMPLETED

Vascular Subphenotypes of Lung Disease in HIV & COPD

NCT01581086

COMPLETED NA

Effect of Exercise and Weight Loss on Cardiovascular Health

NCT01500356

COMPLETED Phase 4

Randomized Trial of High Dose Influenza Vaccine in Long Term Care Setting

NCT01654224

COMPLETED Phase 3

Family Planning-based Partner Abuse Intervention to Reduce Unintended Pregnancy

NCT01459458

COMPLETED NA

Pharmacokinetic Analysis of Posaconazole in Lung Transplant Recipients

NCT01419678

COMPLETED NA

Imaging Airway Liquid Absorption in Cystic Fibrosis

NCT01486199

COMPLETED NA

Pathogenesis of Stress-Induced Cardiomyopathy by I-123 MIBG

NCT01432626

COMPLETED Phase 1

The Feasibility of a Comprehensive Behavioral Intervention in Patient Post TKA

NCT01799772

COMPLETED Phase 3

Buprenorphine for Treatment Resistant Depression

NCT01407575

COMPLETED

Brain Imaging Plus Urodynamics to Investigate the Brain's Control of the Bladder

NCT01619995

COMPLETED

PITT PCI Xience Registry

NCT01299207

COMPLETED Phase 2

Text-message Program to Reduce Risky Sexual Behavior in Young Adult Female Emergency Department (ED) Patients

NCT01548183

COMPLETED NA

Brief Motivational Intervention to Improve Medication Adherence for Adolescents With Bipolar Disorder

NCT03203720

COMPLETED NA

Retaining Cognition While Avoiding Late-Life Depression

NCT01886586

COMPLETED Phase 4

RAPID: Reducing Pain; Preventing Depression

NCT01530204

COMPLETED NA

TREAT (Telemedicine for Reach, Education, Access, and Treatment)

NCT01339208

COMPLETED NA

Text-message Support to Improve Oral Antibiotic Adherence After ED Discharge

NCT01388465

COMPLETED

Anal Human Papillomavirus in Inflammatory Bowel Disease Study

NCT01364896

COMPLETED NA

ECoG Direct Brain Interface for Individuals With Upper Limb Paralysis

NCT01393444

COMPLETED NA

Clinical Implications of Genetic Variations of Venous Stasis Ulceration

NCT02034396

COMPLETED NA

Early Assessment and Intervention for Adolescents at Risk for Bipolar Disorder

NCT03203707

← Previous Page 15 of 25 Next →

Phase Distribution

PhaseTrial count
Phase 1 81
Phase 2 79
Phase 3 28
Phase 4 56

What is open in the University of Pittsburgh pipeline

160 recruiting of 1,238 indexed (13% open); 917 completed (74%).

Phase mix: 84 late (III/IV) vs 160 early (I/II) (early-phase heavy).

Top condition: Depression (17 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

University of Pittsburgh: open-pipeline peers nationwide

Peers matched on 1,238 registered trials and 13% open enrollment, not the therapeutic-area sidebar.

University of Pittsburgh sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 05001,0001,500 12%14%16%18%20%22% Total trials Recruiting share University of PittsburghNorthwestern UniversityEmory UniversityUniversity of Colorado, DenverAstraZenecaIntermountain Health CareMcMaster UniversityNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)Temple University
University of Pittsburgh sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

University of Pittsburgh sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 1,238 trials (± recruiting share)

Sponsors near 13% open enrollment (± trial volume)

What to do with this University of Pittsburgh page

1,238 registered trials is a research-attention snapshot, not an endorsement of University of Pittsburgh or any single study.

  • 160 of University of Pittsburgh's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Depression is the condition University of Pittsburgh studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Depression trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of Pittsburgh pipeline card: 1,238 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.